Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin for Prevention of AKI in Cardiac Surgery
NCT05590143Phase 4Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Jun 2023
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dapagliflozin in acute kidney injury (AKI), sponsored by Amsterdam University Medical Center. Started Jun 2023; status: active, not recruiting.
02
Drugs
dapagliflozin
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT05590143.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05590143.